Effectiveness and Safety of Autologous Fat Transfer in Various Treatment Protocols by Groen, Jan-Willem
  
 
Effectiveness and Safety of Autologous Fat Transfer in
Various Treatment Protocols
Citation for published version (APA):
Groen, J-W. (2018). Effectiveness and Safety of Autologous Fat Transfer in Various Treatment Protocols.
Maastricht: Datawyse / Universitaire Pers Maastricht. https://doi.org/10.26481/dis.20180412jg





Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.




Knowledge gathered through scientific research is particularly of value when it 
serves some form of socio-economic purpose. The description of value, or “val-
orization”, is imperative in justifying the costs that are involved with scientific 
research, costs that are often financed by public authorities, government bodies 
or through funding. In this chapter the valorization of this thesis and the PhD-
trajectory that preceded it will be discussed in the light of its relevance, target 
audiences, products or services, innovation and realization. 
The primary focus of this thesis has been on Autologous Fat Transfer (AFT) in 
breast surgery, which – for the purpose of this discussion - can be divided in 
breast reconstruction and breast augmentation. The main reason for breast 
reconstruction is breast cancer, which is still the most common form of cancer in 
women worldwide with over nearly 1.7 million new cases diagnosed in 2012 1. In 
the Netherlands this translates to one in eight women, but fortunately early 
screening and targeted therapies have greatly improved survival 1,2. Numbers on 
(type of) breast reconstruction performed in the Netherlands are scarce and vary 
greatly but overall it is thought that 30-50% of Dutch women undergo mastec-
tomy and that less than 15% thereof undergo breast reconstruction. The annual 
rate of some form of breast conservative therapy (BCT) is currently estimated at 
60% 3. The primary goal of both forms of reconstruction (following mastectomy 
or BCT) is obtaining the best cosmetic results since unfavorable cosmetic out-
comes have been proven to significantly decrease the quality of life and psycho-
social functioning 4,5. Breast reconstructive options generally encompass the use 
of implants or autologous tissue. The latter can exist of various free or pedicled 
flaps following mastectomy or volume displacement and replacement tech-
niques following BCT. However, using autologous tissue in breast reconstruction 
is not flawless. In some studies complications rates following DIEP reconstruc-
tion and poor cosmetic outcome following dis-/replacement techniques both 
reach 30% respectively 6-10. Furthermore, the widespread use of silicone breast 
implants in both reconstruction and augmentation has recently, again, been 
questioned due to new discoveries in both ASIA syndrome 11 as well as BIA-
ALCL 12. These doubts about silicone implants, brings us to the second focus of 
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this thesis in regard to breast surgery, namely; breast augmentation for cosmet-
ic benefit. Despite the forewarnings about ASIA syndrome and BIA-ALCL the 
number of women who underwent breast augmentation in the Netherlands is 
actually increasing. According to the Dutch Breast Implant Register (DBIR), the 
number of breast operations with the use of implants increased from 6000 in 
2013 to 9000 in 2015 13. Furthermore, out of the 13.600 patients (25.500 im-
plants), that have been recorded between April 2015 and December 2016, 75% 
was treated for cosmetic purposes 13.  
In conclusion, in plastic surgery breast reconstruction and breast augmentation 
are the most frequently performed reconstructive and cosmetic procedures 
respectively. AFT is a potential new technique which may complement or (com-
pletely) replace existing techniques of breast reconstruction/ augmentation. 
Therefore, AFT could potentially become an important attribute to the arma-
mentarium of the breast surgeon. 
Relevance of scientific results  
The relevance of this thesis on breast surgery lies mainly in the endorsement of 
AFT as a novel technique. A technique that has fewer complications and the 
potential to not only complement current methods of breast reconstruction and 
augmentation but also to – one day – replace them. We were able to highlight 
both the efficacy in terms of volume retention and patient’s/ surgeon’s satisfac-
tion and the safety by illustrating currently acceptable oncological recurrence 
rates.  Furthermore, by elaborating on hiatuses between basic science- and clini-
cal studies as well as between the performance of AFT pioneers and less experi-
enced surgeons, we provided a base for future studies. The results from these 
future studies bring us one step closer to successfully implementing this tech-
nique in mainstream breast surgery. It is currently too soon to make compari-
sons in cost-effect analysis between AFT and other forms of breast reconstruc-
tion/ -augmentation. However, a recent study by Sorin et al. estimated the costs 
of a single 500ml AFT procedure, with their apparatus, at 9.28 euro, or 10.52 
USD. Thereby, this thesis is considered to be relevant for future female patients 





The results of this thesis are relevant for researchers and other professionals in 
the medical field with special interest in breast reconstruction and augmenta-
tion. In addition, this thesis is of interest to breast surgeons, surgical oncolo-
gists, plastic surgeons and dedicated nurses. 
Activities and products 
The beauty of a thesis regarding the use of AFT is that it does not directly trans-
late into a certain activity or more importantly; a product. The “product” that is 
used in AFT is – as the name suggests – “autologous”, meaning it is merely re-
distributed, without the addition of synthetic material. However, this does not 
limit its potential since the AFT “activities” – or better indications – are numer-
ous, ranging from volumetric enhancement to the correction of surgical defects.  
Innovation and realization 
The use of AFT in addition to or instead of conventional breast reconstruction or 
augmentation is innovative on its own, i.e. it preludes a whole new chapter in 
the development of breast surgery. As was stated in this thesis there are still 
remaining questions to be answered such as on oncological safety and follow-
up on volume retention. Nonetheless, through the various benefits of AFT that 
have been highlighted in this thesis, the authors, emphasized the undeniable 
place AFT will take in the future repertoire of breast reconstructive possibilities. 
As was discussed in the introduction current breast reconstructive options to 
restore lost volume, consist mainly of the use of either local or distant autolo-
gous tissue or breast implants. Herein, AFT offers numerous options to both aid 
or totally replace these forms of reconstruction. The former is already practiced 
on a large scale with final “touch-up” AFT corrections of small local defects be-
ing common practice in certain centers. The latter will certainly gain more 
recognition when volumetric results from mega-volume enhancement tech-
niques like BRAVA 14,15 become more apparent. Therefore, the author believes 
that with the results from this thesis a more prominent role will be reserved for 
AFT in future breast reconstruction, clinical guidelines.  
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The endorsement of AFT in the Netherlands is an ongoing process that has al-
ready known more than a few hiccups along the way in terms of insurance cov-
erage. Currently, it is mainly hospital funded and on a scientific bases, such as in 
the case of the BREAST-trial (ClinicalTrials.gov identification number 
NCT02339779) 16. Furthermore, it is self-funded by patients in various clinics 
nationwide for cosmetic purposes but with ongoing developments we hope to 
demonstrate its added value and achieve full insurance coverage and implement 
this promising technique in reconstruction patients also. 
Facial rejuvenation and scars 
Besides the indications for AFT in breast surgery, I want to briefly highlight the 
value of its use in facial rejuvenation and in the treatment of scars. Currently, 
facial rejuvenation is realized with surgery and increasingly with the use of der-
mal fillers. While the use of dermal fillers can be seen as a strictly cosmetic pro-
cedure, they can also sometimes be utilized in reconstructive procedures of the 
face. None of the currently available fillers are beatific and since its use is ex-
panding it is appropriate to explore the opportunities of AFT as a potential, 
long-term, biocompatible filler.  
In regard to scars, it has been illustrated in this thesis, that scars can have debili-
tating effects on a person’s quality of life and that important aspects of a scar 
were positively influenced by AFT. Therefore, this thesis provided a stepping 
stone in the process of further investigations on the scar-/ skin healing proper-
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